News | September 26, 2023
Biosergen, Alkem collaborate to develop anti-infective for severe fungal infections
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
Lupin has been exclusively marketing these brands in the Indian market since July 2021
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Clindamycin Phosphate Gel is used to treat acne
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
The market capitalization of the company stood at Rs. 7,000 crore +
Subscribe To Our Newsletter & Stay Updated
